DEXA Scan: Definition, Uses, and Clinical Overview

DEXA Scan Introduction (What it is)

A DEXA Scan is an imaging test that measures bone mineral density (BMD).
It is a diagnostic procedure (test) that uses low-dose X-rays at two energy levels.
It is most commonly used to evaluate fracture risk related to osteoporosis and other bone-loss states.
It is also used in some settings to assess body composition and monitor skeletal health over time.

Why DEXA Scan is used (Purpose / benefits)

Orthopedic and musculoskeletal clinicians often need an objective way to estimate bone strength and fracture risk, especially when bone quality may affect injury patterns, surgical planning, and outcomes. Bone strength is influenced by multiple factors (bone mass, microarchitecture, turnover, geometry), but BMD is a widely used, standardized surrogate measure.

A DEXA Scan is used to:

• Diagnose low bone density (osteopenia/osteoporosis) using standardized scoring systems.
• Estimate fracture risk in the context of clinical risk factors (age, prior fracture, medication exposure, comorbidities).
• Guide clinical decision-making in patients with fragility fractures (fractures from low-energy mechanisms) or those at risk for them.
• Monitor change over time in BMD, such as after initiating or changing osteoporosis therapies or after addressing secondary causes of bone loss.
• Support perioperative planning when bone quality may influence fixation choice, implant selection, or nonunion risk (varies by clinician and case).
• Contribute to multidisciplinary care among orthopedics, primary care, endocrinology, rheumatology, oncology, and geriatrics.

In orthopedic practice, the core problem it addresses is risk reduction—helping identify patients whose skeletal fragility increases the likelihood of fractures and complicates recovery.

Indications (When orthopedic clinicians use it)

Common scenarios where a DEXA Scan is ordered or referenced include:

• Low-trauma (fragility) fracture, such as a hip, vertebral compression, distal radius, or proximal humerus fracture after a fall from standing height.
• Postmenopausal patients or older adults where fracture risk assessment is clinically relevant (thresholds vary by guideline, clinician, and case).
• Long-term glucocorticoid exposure or other medications associated with bone loss (risk depends on dose, duration, and patient factors).
• Suspected secondary osteoporosis, including endocrine, renal, gastrointestinal, inflammatory, or malabsorptive conditions.
• Preoperative assessment when bone quality may affect fixation strategy in spine, trauma, or arthroplasty planning (varies by clinician and case).
• History of vertebral height loss or radiographic concern for compression fracture, to complement clinical evaluation.
• Monitoring known low BMD, especially when treatment has been started or when there is concern for progression.
• Body composition assessment in select settings (sports medicine, metabolic health, sarcopenia research), depending on availability and clinical goals.

Contraindications / when it is NOT ideal

A DEXA Scan has relatively few absolute contraindications, but there are situations where it is not ideal or results may be misleading:

• Pregnancy: usually avoided unless the benefit clearly outweighs risk (approach varies by clinician and facility).
• Recent contrast studies or nuclear medicine scans: barium or radiotracers can create artifacts; timing recommendations vary by facility protocol.
• Inability to position safely: severe pain, inability to lie flat, or contractures may limit accurate measurement.
• Weight or body size beyond table limits: may prevent scanning or reduce accuracy (limits vary by equipment model).
• Anatomic distortion or artifacts at the measurement site, which can falsely elevate or reduce BMD, such as:
• Advanced degenerative spine changes (osteophytes, facet arthropathy)
• Vertebral fractures or scoliosis affecting region-of-interest selection
• Orthopedic hardware (spinal instrumentation, hip arthroplasty)
• Aortic calcification overlying the lumbar spine
• Clinical questions requiring different information: DEXA Scan measures BMD but not bone microarchitecture; alternative imaging may be more informative in selected cases.

In these contexts, clinicians may rely on alternative sites (e.g., hip vs spine), adjunct tools, or different imaging modalities to reduce interpretive pitfalls.

How it works (Mechanism / physiology)

A DEXA Scan uses dual-energy X-ray absorptiometry. In simple terms, two different X-ray energy levels pass through the body, and the scanner analyzes how much of each beam is absorbed. Because bone attenuates X-rays differently than soft tissue, the system can estimate areal bone mineral density (typically reported as grams per square centimeter).

Key musculoskeletal concepts tied to interpretation:

• Bone tissue involved: predominantly cortical and trabecular bone, depending on the site measured.
• The lumbar spine is relatively trabecular-rich and may show metabolic changes earlier, but it is prone to artifact from degeneration.
• The proximal femur (hip) includes cortical and trabecular compartments and is strongly tied to clinically meaningful fracture outcomes.
• BMD vs bone strength: BMD correlates with fracture risk, but fractures also reflect fall mechanics, neuromuscular control, medications, and bone quality features not directly captured by DEXA Scan.
• Scores and clinical interpretation:
• A T-score compares the patient’s BMD to a young adult reference population and is commonly used to classify osteoporosis in postmenopausal patients and older men (criteria depend on guideline context).
• A Z-score compares BMD to an age- and sex-matched reference population and is often used in premenopausal patients, younger men, and children.
• Time course and reversibility: Bone remodeling is slow. Meaningful changes in BMD generally occur over months to years, so repeat testing intervals are typically not short and vary by clinician and case.

DEXA Scan results should be interpreted alongside clinical risk factors, fracture history, and—when appropriate—laboratory evaluation for secondary causes of bone loss.

DEXA Scan Procedure overview (How it is applied)

A DEXA Scan is usually an outpatient test with a straightforward workflow:

1. History/exam context
   The clinician identifies why BMD information is needed (fragility fracture, medication risk, comorbidities, monitoring). This context guides which sites are most relevant and how results will be used.

2. Imaging/diagnostics decision
   DEXA Scan is selected as the primary BMD test in many settings. If artifacts are likely (hardware, severe degeneration), the clinician may plan alternative sites or adjunct assessments.

3. Preparation (facility-specific)
   Patients are commonly asked about recent contrast studies and instructed to avoid certain supplements immediately before the test depending on protocol (varies by facility). Metal objects near the scanning field are typically removed to reduce artifact.

4. Testing
   The patient lies on a scanning table while the scanner passes over targeted regions (commonly lumbar spine and hip). The test is noninvasive and typically does not require injections or sedation.

5. Immediate checks
   The technologist reviews image quality and positioning. If motion or artifacts compromise accuracy, the scan may be repeated during the same visit.

6. Follow-up
   A radiologist or trained interpreting clinician reports BMD values and scores. The ordering clinician integrates results with clinical risk assessment and determines whether additional evaluation is needed (varies by clinician and case).

Types / variations

DEXA Scan technology is used in several clinically relevant ways:

• Central DEXA Scan (axial DEXA)
  Measures the lumbar spine and proximal femur. This is the standard approach for diagnosing osteoporosis and assessing fracture risk in many guidelines.

• Peripheral DEXA Scan (pDEXA)
  Measures sites such as the forearm, heel, or finger. It may be used for screening or when central sites cannot be measured, though results are not always interchangeable with central measurements.

• Forearm (radius) DEXA Scan
  Often used when hip/spine cannot be interpreted (e.g., bilateral hip arthroplasty, significant spine artifact) or in certain metabolic bone conditions where cortical bone assessment is particularly relevant.

• Whole-body DEXA Scan
  Can estimate body composition (lean mass and fat mass distribution) and total body bone content. This is used in selected clinical and research settings rather than routine osteoporosis diagnosis.

• Serial (follow-up) DEXA Scan
  Repeat testing aimed at monitoring change. Interpretation often incorporates concepts like measurement precision and whether change exceeds expected variability (methodology varies by facility and software).

Pros and cons

Pros:

• Noninvasive and typically quick to perform
• Uses low radiation dose compared with many other imaging tests
• Provides standardized, widely recognized metrics (e.g., T-score, Z-score)
• Strong clinical integration with fracture risk assessment frameworks
• Useful for monitoring trends over time when performed consistently
• Broad availability in many healthcare systems
• Can measure hip and spine, which are key fracture-relevant sites

Cons:

• Measures areal BMD, not bone microarchitecture or true volumetric density
• Artifacts can distort results, especially in the lumbar spine (degeneration, calcifications, fractures, hardware)
• Accuracy depends on positioning, calibration, and consistent technique across serial scans
• Less informative for acute pain evaluation (e.g., does not diagnose an acute fracture by itself)
• Body size limits and soft-tissue variability can affect feasibility and precision
• May not capture regional focal weakness relevant to specific orthopedic constructs
• Different machines/software may yield non-identical values, complicating comparisons if testing sites change

Aftercare & longevity

A DEXA Scan itself requires little to no “aftercare” because it is noninvasive and does not create tissue injury. The more meaningful “after” component is how results are used over time.

Practical factors that affect how DEXA Scan results are applied and how long they remain clinically useful include:

• Baseline fracture risk and clinical context: A single result is interpreted differently in someone with a prior fragility fracture versus someone undergoing routine risk screening.
• Site-specific issues: Hip results may be more reliable than spine results when degenerative changes are prominent; conversely, hip hardware may push interpretation toward the forearm (choice varies by clinician and case).
• Intercurrent events: New fractures, major weight change, new medications, endocrine changes, or immobilization can shift risk and prompt reassessment.
• Serial measurement strategy: Repeat scans are most interpretable when performed on the same machine with similar positioning and analysis, and at intervals that allow physiologic change beyond expected measurement variation (interval varies by clinician and case).
• Comorbidities and secondary causes: Conditions affecting bone turnover can influence whether clinicians pursue additional testing (labs, alternative imaging) in parallel with BMD monitoring.

In general, DEXA Scan results are a snapshot of bone density at that point in time; clinical decisions often rely on both the measured values and the patient’s evolving risk profile.

Alternatives / comparisons

DEXA Scan is a cornerstone for BMD assessment, but it is not the only approach. Alternatives and complements include:

• FRAX-style clinical risk calculators (with or without BMD)
  These tools combine clinical risk factors (and sometimes femoral neck BMD) to estimate fracture probability. They complement DEXA Scan rather than replacing it, and applicability varies by population and guideline.

• Quantitative computed tomography (QCT)
  Provides volumetric BMD and can separate cortical from trabecular compartments. It may be helpful when DEXA Scan is difficult to interpret, but it generally involves higher radiation and different availability.

• Opportunistic CT measures
  Some clinicians use CT data obtained for other reasons to infer bone density surrogates (technique and validation vary by scanner, protocol, and software). This is not a universal substitute for a formal DEXA Scan.

• Quantitative ultrasound (QUS)
  Often performed at the heel. It can be used for screening in some settings, but it does not directly measure central hip/spine BMD and may not be interchangeable with DEXA Scan for diagnosis/monitoring.

• Plain radiographs (X-rays)
  Useful for identifying fractures, deformity, and degenerative disease, but not sensitive for early bone loss. Osteopenia on X-ray is typically a late and subjective finding.

• Bone scintigraphy or PET
  Evaluates metabolic activity and lesions rather than BMD. These tests address different clinical questions (e.g., metastatic disease, occult fracture), not routine osteoporosis assessment.

• Laboratory evaluation
  Blood and urine tests do not measure BMD but may identify secondary contributors (e.g., vitamin D abnormalities, thyroid/parathyroid issues). Labs are often complementary when the clinical picture suggests secondary osteoporosis.

DEXA Scan Common questions (FAQ)

Q: Is a DEXA Scan the same as a “bone scan”?
No. A DEXA Scan measures bone mineral density, while a nuclear medicine bone scan evaluates bone metabolic activity and can highlight areas of increased turnover (for example, some fractures, infections, or tumors). They answer different clinical questions.

Q: Does a DEXA Scan hurt?
A DEXA Scan is typically painless because it is noninvasive. The main discomfort, when present, comes from lying still or positioning, especially in patients with back or hip pain.

Q: Do you need anesthesia or sedation for a DEXA Scan?
Anesthesia is not typically used. The test is performed while awake and requires only brief stillness.

Q: How long does a DEXA Scan take?
Timing varies by facility and the type of scan, but it is commonly completed within a short appointment. Additional time may be needed if positioning is difficult or if extra sites (like the forearm) are included.

Q: How safe is the radiation from a DEXA Scan?
A DEXA Scan uses a low dose of X-ray radiation compared with many other imaging studies. Even so, radiation exposure is considered in decision-making, especially in pregnancy, and policies vary by clinician and facility.

Q: What do T-scores and Z-scores mean?
A T-score compares bone density to a young adult reference population and is commonly used for diagnostic classification in postmenopausal patients and older men. A Z-score compares to an age- and sex-matched population and is often emphasized in younger patients. Interpretation depends on clinical context and guideline standards.

Q: Can arthritis or spine degeneration affect DEXA Scan results?
Yes. Degenerative changes, osteophytes, vertebral fractures, and calcifications can artificially increase measured lumbar spine BMD. Clinicians often consider hip or forearm measurements when spine values are likely to be confounded.

Q: How often should a DEXA Scan be repeated?
There is no single universal schedule. Repeat intervals depend on baseline results, fracture history, risk factors, and whether results will change management; this varies by clinician and case.

Q: Will I have activity or work restrictions after a DEXA Scan?
Usually not, because it is a noninvasive test without sedation or injections. If restrictions exist, they are typically related to the underlying condition being evaluated rather than the scan itself.

Q: How much does a DEXA Scan cost?
Cost varies widely by country, healthcare system, insurance coverage, and facility. Many institutions can provide an estimate in advance, and coverage criteria may depend on indication and local policy.